Advantage Alpha Capital Partners’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$305K	Sell	11,020 -2,577	-19%	-$71.3K	0.08%	110
2025 Q1	$302K	Buy	13,597 +4,707	+53%	+$105K	0.07%	104
2024 Q4	$176K	Sell	8,890 -11,477	-56%	-$227K	0.04%	147
2024 Q3	$509K	Sell	20,367 -10,891	-35%	-$272K	0.12%	118
2024 Q2	$584K	Buy	+31,258	New	+$584K	0.13%	97